Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Total Debt / (EBITDA-CAPEX)

Arena Pharmaceuticals Total Debt / (EBITDA-CAPEX) Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Total Debt / (EBITDA-CAPEX) from 2012 to 2016.
  • Arena Pharmaceuticals Total Debt / (EBITDA-CAPEX) for the quarter ending December 12, 2016 was $0m
  • Arena Pharmaceuticals Total Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2017 was $11m a -0.29% decrease of 0m year over year
Other Ratios Metrics:
  • Arena Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $10m a -127.22% decrease of -13m year over year
  • Arena Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
  • Arena Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $11m a -165.14% decrease of -19m year over year
View Chart On Koyfin

Quarterly ARNA Total Debt / (EBITDA-CAPEX) Data

12/2016$0m
06/2013$0m
06/2012$4m

Annual ARNA Total Debt / (EBITDA-CAPEX) Data

2016$3m